Skip to main content
Premium Trial:

Request an Annual Quote

PathoGenetix Picks Sagentia to Develop Commercial-Scale Microbial Detection System

NEW YORK (GenomeWeb News) – Sagentia said today that it has been picked by PathoGenetix to develop a commercial scale system for rapid microbial detection and strain typing based on the Woburn, Mass.-based firm's Genome Sequence Scanning technology.

PathoGenetix plans to launch the system's first commercial application, for the research market, in late 2012.

In turning the current laboratory prototype of the GSS technology into a "technically and commercially successful platform," Sagentia said it will continue integrating state-of-the-art optics and microfluidics, making the technology more robust, improving its usability, reducing costs, and increasing manufacturing efficiency.

The GSS technology was developed with more than $50 million from the US Departments of Defense and Homeland Security and combines automated sample preparation and single molecule detection to detect and characterize microbes from complex biological samples in as little as three hours.

In November PathoGenetix said it had raised $7.5 million on top of $4 million raised in August to develop and commercialize the technology.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.